Moderna

Moderna Debt

The Debt of Moderna (MRNA) as of Oct 9, 2026 is 610.00 M USD. In the previous year, Debt was 62.00 M USD — a change of 883.87% (higher).

Debt

610.00 MUSD

YoY

883.87%

Last updated:

In 2025, Moderna's total debt was 610.00 M USD, a 883.87% change from the 62.00 M USD total debt recorded in the previous year.

The Moderna Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
33.00 M USD
Jan 1, 2019
39.00 M USD
Jan 1, 2020
134.00 M USD
Jan 1, 2021
764.00 M USD
Jan 1, 2022
1.07 B USD
Jan 1, 2023
575.00 M USD
Jan 1, 2024
62.00 M USD
Jan 1, 2025
610.00 M USD
The Moderna Debt history
YEARDebtYoY
610.00 MUSD+883.87%
62.00 MUSD-89.22%
575.00 MUSD-46.41%
1.07 BUSD+40.45%
764.00 MUSD+470.15%
134.00 MUSD+243.59%
39.00 MUSD+18.18%
33.00 MUSD+106.25%
16.00 MUSD+23.08%
13.00 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Debt Details

Understanding Moderna's Debt Structure

Moderna's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Moderna's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Moderna’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Moderna’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Moderna stock

Debt of Moderna is 610.00 M USD in 2025.

Debt of Moderna changed from 62.00 M USD to 610.00 M USD, representing a 883.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Moderna since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Moderna historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Moderna

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Moderna